Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with an error screen. Navigation and related study details are no longer visible.SummaryDifference21%

- Check48 days agoChange DetectedRevision metadata on the page shows a new version, v3.6.6, has been published to replace the prior v3.6.5. This indicates a minor update to the page rather than a change to the study details.SummaryDifference0.0%

- Check55 days agoChange DetectedA funding note indicating NIH grant/contract support in 2015 was added to the study record, documenting the source of funding.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing Revision: v3.6.4, indicating a version update at the site level. This change does not modify the study details or other user-facing content on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a newer version of the page/document in the system.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.